The Opioid Partnership
Founded in 2018, the Opioid Partnership is a coalition of organizations and individuals working to expand support for mothers and babies affected by the opioid crisis.
The opioid epidemic impacts every segment of society in the U.S., including women and their babies. Opioid use during pregnancy can result in a drug withdrawal syndrome in newborns called neonatal abstinence syndrome (NAS). An estimated 32,000 babies were born with NAS in 2014. One baby is born with signs of NAS every 15 minutes in the U.S., this equates to nearly 100 babies a day.
More assistance is needed to support pregnant women and their babies, in communities across the U.S., including:
- Supporting adoption of preventive strategies to support and protect pregnant women and their babies
- Identifying health problems, developmental delays, and functional disabilities in newborns quickly, so that support can be provided
- Linking pregnant women and their newborns to medical and social services
- Sharing lessons learned to inform and improve prevention strategies, safe medication use, and clinical management for pregnant women and their babies in communities across the United States
The Opioid Partnership supports mothers and babies impacted by the opioid crisis by identifying promising, innovative solutions and advocating for increased funding and support in the following areas, with a focus on the needs of pregnant women and their babies:
- Engagement and prevention strategies
- Use of data to identify individuals that need support; improve understanding of short and long-term outcomes of prenatal opioid abuse; and identify interventions that have positive impact
- Linking affected families with medical and social services
For More Information
For more information contact email@example.com.